Inherited retinal dystrophies that belong to the group of pigmentary retinopathies.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
The documentation for cone-rod dystrophy is limited primarily due to its rarity, affecting fewer than 10,000 individuals in the U.S. This low prevalence results in fewer systematic clinical studies and published data. Additionally, the genetic basis of CRD is complex and still being characterized, which contributes to the challenges in understanding the full spectrum of clinical features.
To navigate your care for cone-rod dystrophy, consider seeking a retinal specialist or an ophthalmologist with expertise in inherited retinal diseases. These professionals can provide tailored guidance and management strategies. Additionally, genetic counseling may be beneficial to understand potential familial implications. While there are no specific patient organizations identified for CRD, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials may also be a viable option, as they can offer access to cutting-edge therapies.
Currently, there are 19 active clinical trials focused on cone-rod dystrophy. These trials explore various therapeutic approaches and interventions aimed at improving visual function or slowing disease progression. For more information on these trials, you can visit ClinicalTrials.gov and search for 'cone-rod dystrophy' at https://clinicaltrials.gov/search?cond=cone-rod%20dystrophy. This ongoing research offers hope for future treatment options.
Actionable guidance for navigating care for cone-rod dystrophy
To navigate your care for cone-rod dystrophy, consider seeking a retinal specialist or an ophthalmologist with expertise in inherited retinal diseases. These professionals can provide tailored guidance and management strategies. Additionally, genetic counseling may be beneficial to understand potential familial implications. While there are no specific patient organizations identified for CRD, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials may also be a viable option, as they can offer access to cutting-edge therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.